Rosetta Genomics Ltd.
(Other OTC/NBB : ROSG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.96%310.420.0%$5225.43m
BNTXBioNTech SE 3.25%344.330.0%$1582.56m
NVAXNovavax, Inc. -0.92%160.4878.2%$849.64m
AMGNAmgen, Inc. 0.49%202.161.4%$596.16m
GILDGilead Sciences, Inc. -0.22%69.521.0%$508.69m
VRTXVertex Pharmaceuticals, Inc. -0.71%202.991.9%$475.58m
REGNRegeneron Pharmaceuticals, Inc. -1.10%627.012.7%$468.81m
LGVNLongeveron Inc. 17.78%21.200.0%$422.79m
ILMNIllumina, Inc. -3.12%346.333.3%$315.11m
SNSSSunesis Pharmaceuticals, Inc. -2.57%4.170.7%$291.50m
BIIBBiogen, Inc. -2.42%223.001.8%$272.25m
OCGNOcugen, Inc. -9.05%5.740.0%$192.62m
INCYIncyte Corp. -1.52%65.622.4%$153.86m
EXASEXACT Sciences Corp. -5.37%76.2418.0%$147.67m
SGENSeagen Inc. -4.92%150.875.8%$143.95m

Company Profile

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.